Natural Products from Deep-Sea-Derived Fungi ̶ A New Source of Novel Bioactive Compounds?

Author(s): Georgios Daletos, Weaam Ebrahim, Elena Ancheeva, Mona El-Neketi, Weiguo Song, Wenhan Lin, Peter Proksch*

Journal Name: Current Medicinal Chemistry

Volume 25 , Issue 2 , 2018

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer


Background: Over the last two decades, deep-sea-derived fungi are considered to be a new source of pharmacologically active secondary metabolites for drug discovery mainly based on the underlying assumption that the uniqueness of the deep sea will give rise to equally unprecedented natural products. Indeed, up to now over 200 new metabolites have been identified from deep-sea fungi, which is in support of the statement made above.

Results: This review summarizes the new and/or bioactive compounds reported from deepsea- derived fungi in the last six years (2010 – October 2016) and critically evaluates whether the data published so far really support the notion that these fungi are a promising source of new bioactive chemical entities.

Keywords: Deep-sea fungi, extremophiles, natural products, bioactive metabolites, drug discovery, bioprospecting.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2018
Page: [186 - 207]
Pages: 22
DOI: 10.2174/0929867324666170314150121
Price: $65

Article Metrics

PDF: 83
PRC: 1